Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Recenti Progressi in Medicina
|
March 1, 1991
[Value and limitations of neoplasm markers in the diagnosis of pancreatic carcinoma]
C Fabris, D Basso, T Meggiato, et al.
Urology
|
May 3, 2000
Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when?
D Basso, P Fogar, M G Piva, et al.
Oncology
|
November 30, 2000
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging
M G Piva, F Navaglia, D Basso, et al.
Anticancer Research
|
November 1, 1994
Diabetes mellitus in pancreatic cancer follow-up
P Fogar, C Pasquali, D Basso, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 16, 1998
Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer
P Fogar, D Basso, C Pasquali, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
November 14, 2000
ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications
C Zambon, F Navaglia, D Basso, et al.
The International Journal of Biological Markers
|
January 10, 2006
Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1
E Greco, D Basso, P Fogar, et al.
Annals of Clinical Research
|
January 1, 1988
C reactive protein in pancreatic cancer and chronic pancreatitis
D Basso, C Fabris, A Meani, et al.
Journal of Clinical Pathology
|
May 1, 1990
Oxygen derived free radicals in patients with chronic pancreatic and other digestive diseases
D Basso, M P Panozzo, C Fabris, et al.
Journal of Medicine
|
January 1, 1991
Role of local and systemic factors in increasing serum glycoprotein markers of pancreatic cancer
C Fabris, D Basso, A Piccoli, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Recenti Progressi in Medicina
|
March 1, 1991
[Value and limitations of neoplasm markers in the diagnosis of pancreatic carcinoma]
C Fabris, D Basso, T Meggiato, et al.
Urology
|
May 3, 2000
Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when?
D Basso, P Fogar, M G Piva, et al.
Oncology
|
November 30, 2000
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging
M G Piva, F Navaglia, D Basso, et al.
Anticancer Research
|
November 1, 1994
Diabetes mellitus in pancreatic cancer follow-up
P Fogar, C Pasquali, D Basso, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 16, 1998
Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer
P Fogar, D Basso, C Pasquali, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
November 14, 2000
ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications
C Zambon, F Navaglia, D Basso, et al.
The International Journal of Biological Markers
|
January 10, 2006
Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1
E Greco, D Basso, P Fogar, et al.
Annals of Clinical Research
|
January 1, 1988
C reactive protein in pancreatic cancer and chronic pancreatitis
D Basso, C Fabris, A Meani, et al.
Journal of Clinical Pathology
|
May 1, 1990
Oxygen derived free radicals in patients with chronic pancreatic and other digestive diseases
D Basso, M P Panozzo, C Fabris, et al.
Journal of Medicine
|
January 1, 1991
Role of local and systemic factors in increasing serum glycoprotein markers of pancreatic cancer
C Fabris, D Basso, A Piccoli, et al.
Page
of 5